Annual long term liabilities:
$71.84M+$40.28M(+127.60%)Summary
- As of today (May 23, 2025), TARS annual total long term liabilities is $71.84 million, with the most recent change of +$40.28 million (+127.60%) on December 31, 2024.
- During the last 3 years, TARS annual long term liabilities has risen by +$71.15 million (+10178.25%).
- TARS annual long term liabilities is now at all-time high.
Performance
TARS Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$71.98M+$139.00K(+0.19%)Summary
- As of today (May 23, 2025), TARS quarterly total long term liabilities is $71.98 million, with the most recent change of +$139.00 thousand (+0.19%) on March 31, 2025.
- Over the past year, TARS quarterly long term liabilities has increased by +$40.45 million (+128.24%).
- TARS quarterly long term liabilities is now -30.70% below its all-time high of $103.87 million, reached on September 30, 2020.
Performance
TARS quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TARS Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +127.6% | +128.2% |
3 y3 years | +10000.0% | +265.9% |
5 y5 years | +13.1% | - |
TARS Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | -1.4% | +268.5% |
5 y | 5-year | at high | >+9999.0% | -30.7% | >+9999.0% |
alltime | all time | at high | >+9999.0% | -30.7% | >+9999.0% |
TARS Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $71.98M(+0.2%) |
Dec 2024 | $71.84M(+127.6%) | $71.84M(-1.5%) |
Sep 2024 | - | $72.95M(-0.1%) |
Jun 2024 | - | $73.03M(+131.5%) |
Mar 2024 | - | $31.54M(-0.1%) |
Dec 2023 | $31.57M(+61.6%) | $31.57M(+0.5%) |
Sep 2023 | - | $31.42M(+18.9%) |
Jun 2023 | - | $26.43M(+7.6%) |
Mar 2023 | - | $24.55M(+25.7%) |
Dec 2022 | $19.53M | $19.53M(-0.2%) |
Sep 2022 | - | $19.57M(-0.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $19.61M(-0.4%) |
Mar 2022 | - | $19.68M(+2714.9%) |
Dec 2021 | $699.00K(+15.5%) | $699.00K(-22.8%) |
Sep 2021 | - | $905.00K(+72.7%) |
Jun 2021 | - | $524.00K(-13.2%) |
Mar 2021 | - | $604.00K(-0.2%) |
Dec 2020 | $605.00K(-99.0%) | $605.00K(-99.4%) |
Sep 2020 | - | $103.87M(>+9900.0%) |
Jun 2020 | - | $797.00K(-98.7%) |
Dec 2019 | $63.50M(+1681.8%) | $63.50M |
Dec 2018 | $3.56M | - |
FAQ
- What is Tarsus Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual long term liabilities year-on-year change?
- What is Tarsus Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Tarsus Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of TARS is $71.84M
What is the all time high annual long term liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual total long term liabilities is $71.84M
What is Tarsus Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, TARS annual total long term liabilities has changed by +$40.28M (+127.60%)
What is Tarsus Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of TARS is $71.98M
What is the all time high quarterly long term liabilities for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly total long term liabilities is $103.87M
What is Tarsus Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, TARS quarterly total long term liabilities has changed by +$40.45M (+128.24%)